Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
Submitted by
admin
on November 16, 2009 - 9:11am
Source:
Yahoo/AP
News Tags:
GSK
Nabi
vaccines
partnerships
smoking cessation
Headline:
GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
Do Not Allow Advertisers to Use My Personal information
